Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF) (vol 16, e0251658, 2021)PLOS ONEIF2.62025-10-290OAAI
Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic modelsCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32024-11-050OAAI
Increasing Accessibility of Bayesian Network-Based Defined Approaches for Skin Sensitisation Potency AssessmentTOXICSIF4.12024-09-120OAAI
In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its estersARCHIVES OF TOXICOLOGYIF6.92024-04-240OAAI
Enhancement of Skin Permeability Prediction through PBPK Modeling, Bayesian Inference, and Experiment Design通过PBPK建模,贝叶斯推理和实验设计增强皮肤渗透性预测PHARMACEUTICSIF5.52023-11-241OAAI
Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico studyARCHIVES OF TOXICOLOGYIF6.92023-10-112OAAI
The role of a molecular informatics platform to support next generation risk assessmentCOMPUTATIONAL TOXICOLOGYIF2.92023-05-018OAAI
Prediction of in vivo prenatal chlorpyrifos exposure leading to developmental neurotoxicity in humans based on in vitro toxicity data by quantitative in vitro-in vivo extrapolationFRONTIERS IN PHARMACOLOGYIF4.82023-03-077OAAI
Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data (Sep, 10.1007/s00204-022-03371-6, 2022)ARCHIVES OF TOXICOLOGYIF6.92022-11-270OAAI
Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical dataARCHIVES OF TOXICOLOGYIF6.92022-09-233OAAI
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessmentARCHIVES OF TOXICOLOGYIF6.92022-09-0518OAAI
A Mechanistic Bayesian Inferential Workflow for Estimation of In Vivo Skin Permeation from In Vitro MeasurementsJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82022-03-018PRE
Cosmetics Europe evaluation of 6 in silico skin penetration modelsCOMPUTATIONAL TOXICOLOGYIF2.92021-08-0120OAAI
Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-01-0125PREAI
Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and IIBIOORGANIC & MEDICINAL CHEMISTRYIF32018-08-0122PREAI
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 KinasesMOLECULESIF4.62017-11-23160OAAI
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1RJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRYIF5.42017-01-184OAAI